Mini Review

Published on 18 Mar 2015

NK cell tolerance as the final endorsement of prenatal tolerance after in utero hematopoietic cellular transplantation

in Integrative and Regenerative Pharmacology

Amir M. Alhajjat
Amanda E. Lee
Beverly S. Strong
Aimen F. Shaaban

Frontiers in Pharmacology

doi 10.3389/fphar.2015.00051

4,568 views
14 citations

General Commentary

Published on 03 Mar 2015

Corrigendum: In utero therapy for congenital disorders using amniotic fluid stem cells

in Integrative and Regenerative Pharmacology

Durrgah L. Ramachandra
Sheng-Wen Steven Shaw
Panicos Shangaris
Stavros Loukogeorgakis
Pascale V. Guillot
Paolo De Coppi
Anna L. David

Frontiers in Pharmacology

doi 10.3389/fphar.2015.00039

5,734 views
1 citation

Opinion

Published on 10 Feb 2015

Consensus statement from the first international conference for in utero stem cell transplantation and gene therapy

in Integrative and Regenerative Pharmacology

Tippi C. MacKenzie
Anna L. David
Alan W. Flake
Graca Almeida-Porada

Frontiers in Pharmacology

doi 10.3389/fphar.2015.00015

6,052 views
35 citations

Original Research

Published on 03 Feb 2015

Inhibition of histone deacetylase (HDAC) by 4-phenylbutyrate results in increased junctional conductance between rat corpora smooth muscle cells

in Integrative and Regenerative Pharmacology

Hong Zhan Wang
Barbara Rosati
Chris Gordon
Virginijus Valiunas
David McKinnon
Ira S. Cohen
Peter R. Brink

Frontiers in Pharmacology

doi 10.3389/fphar.2015.00009

3,740 views
4 citations

Mini Review

Published on 12 Jan 2015

In utero hematopoietic cell transplantation for hemoglobinopathies

in Integrative and Regenerative Pharmacology

S. Christopher Derderian
Cerine Jeanty
Mark C. Walters
Elliott Vichinsky
Tippi C. MacKenzie

Frontiers in Pharmacology

doi 10.3389/fphar.2014.00278

8,988 views
30 citations

Review

Published on 06 Jan 2015

Immunological considerations in in utero hematopoetic stem cell transplantation (IUHCT)

in Integrative and Regenerative Pharmacology

Andrea I. Loewendorf
Marie Csete
Alan Flake

Frontiers in Pharmacology

doi 10.3389/fphar.2014.00282

6,152 views
10 citations

Review

Published on 19 Dec 2014

In utero therapy for congenital disorders using amniotic fluid stem cells

in Integrative and Regenerative Pharmacology

Durrgah L. Ramachandra
Steven S. W. Shaw
Panicos Shangaris
Stavros Loukogeorgakis
Pascale V. Guillot
Paolo De Coppi
Anna L. David

Frontiers in Pharmacology

doi 10.3389/fphar.2014.00270

13,950 views
31 citations

Review

Published on 11 Dec 2014

Hemophilia A: an ideal disease to correct in utero

in Integrative and Regenerative Pharmacology

Christopher D. Porada
Christopher Rodman
Glicerio Ignacio
Anthony Atala
Graça Almeida-Porada

Frontiers in Pharmacology

doi 10.3389/fphar.2014.00276

15,503 views
18 citations

Mini Review

Published on 12 Nov 2014

In utero hematopoietic cell transplantation: induction of donor specific immune tolerance and postnatal transplants

in Integrative and Regenerative Pharmacology

William H. Peranteau

Frontiers in Pharmacology

doi 10.3389/fphar.2014.00251

4,885 views
10 citations

Mini Review

Published on 09 Oct 2014

Prenatal transplantation of mesenchymal stem cells to treat osteogenesis imperfecta

in Integrative and Regenerative Pharmacology

Jerry K. Y. Chan
Cecilia Götherström

Frontiers in Pharmacology

doi 10.3389/fphar.2014.00223

10,849 views
34 citations

Opinion

Published on 17 Sep 2014

Cell-based interventions in utero: time to reconsider

in Integrative and Regenerative Pharmacology

Nancy M. P. King
Ana S. Iltis

Frontiers in Pharmacology

doi 10.3389/fphar.2014.00214

4,392 views
2 citations

Review

Published on 07 Jan 2014

The emerging role of oxylipins in thrombosis and diabetes

in Integrative and Regenerative Pharmacology

Benjamin Eric Tourdot
Intekhab Ahmed
Michael Holinstat

Frontiers in Pharmacology

doi 10.3389/fphar.2013.00176

12,169 views
80 citations

Original Research

Published on 01 Oct 2013

Beyond osteogenesis: an in vitro comparison of the potentials of six bone morphogenetic proteins

in Integrative and Regenerative Pharmacology

Jessica C Rivera
Cassandra A Strohbach
Joseph C Wenke
Christopher R Rathbone

Frontiers in Pharmacology

doi 10.3389/fphar.2013.00125

7,432 views
34 citations

Review

Published on 22 Aug 2013

Physiological and pharmacological aspects of the vas deferens—an update

in Integrative and Regenerative Pharmacology

David Stewart Koslov
Karl-Erik Andersson

Frontiers in Pharmacology

doi 10.3389/fphar.2013.00101

29,899 views
51 citations

Original Research

Published on 10 Jan 2012

Time Course of Altered Sensitivity to Inhibitory and Excitatory Agonist Responses in the Longitudinal Muscle–Myenteric Plexus and Analgesia in the Guinea Pig after Chronic Morphine Treatment

in Integrative and Regenerative Pharmacology

Dane M Barrett
Hercules Tarambirwa Maguma
David A Taylor

Frontiers in Pharmacology

doi 10.3389/fphar.2011.00088

3,936 views
3 citations

Original Research

Published on 09 Jan 2012

Chronic Administration of a Leupeptin-Derived Calpain Inhibitor Fails to Ameliorate Severe Muscle Pathology in a Canine Model of Duchenne Muscular Dystrophy

in Integrative and Regenerative Pharmacology

Martin K Childers
Janet R Bogan
Daniel J Bogan
Hansel Greiner
Melanie Holder
Robert Grange
Joe N Kornegay

Frontiers in Pharmacology

doi 10.3389/fphar.2011.00089

5,388 views
21 citations

Navigation group

Articles

NK cell tolerance as the final endorsement of prenatal tolerance after in utero hematopoietic cellular transplantation

Corrigendum: In utero therapy for congenital disorders using amniotic fluid stem cells

Consensus statement from the first international conference for in utero stem cell transplantation and gene therapy

Inhibition of histone deacetylase (HDAC) by 4-phenylbutyrate results in increased junctional conductance between rat corpora smooth muscle cells

In utero hematopoietic cell transplantation for hemoglobinopathies

Immunological considerations in in utero hematopoetic stem cell transplantation (IUHCT)

In utero therapy for congenital disorders using amniotic fluid stem cells

Hemophilia A: an ideal disease to correct in utero

In utero hematopoietic cell transplantation: induction of donor specific immune tolerance and postnatal transplants

Prenatal transplantation of mesenchymal stem cells to treat osteogenesis imperfecta

Cell-based interventions in utero: time to reconsider

The emerging role of oxylipins in thrombosis and diabetes

Beyond osteogenesis: an in vitro comparison of the potentials of six bone morphogenetic proteins

Physiological and pharmacological aspects of the vas deferens—an update

Time Course of Altered Sensitivity to Inhibitory and Excitatory Agonist Responses in the Longitudinal Muscle–Myenteric Plexus and Analgesia in the Guinea Pig after Chronic Morphine Treatment

Chronic Administration of a Leupeptin-Derived Calpain Inhibitor Fails to Ameliorate Severe Muscle Pathology in a Canine Model of Duchenne Muscular Dystrophy